Recruiting
Metabolic dysfunction-associated steatohepatitis+1
RecruitingStudy of Namodenoson Treatment in Patients with Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis
Investigational
Study of Namodenoson Treatment in Patients with Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis
Investigational
- Disease:Metabolic dysfunction-associated steatohepatitisNon-alcoholic steatohepatitis
- Substances:Namodenoson
Countries:
Bulgaria
Bulgaria- Participants:18–64 years · 65+ years
- Substances:Namodenoson


